| Food for thought… integrated testing strategies for safety assessments T Hartung, T Luechtefeld, A Maertens, A Kleensang Altex 30 (1), 3, 2013 | 263* | 2013 |
| T4 report: Toward good read-across practice (GRAP) guidance N Ball, MTD Cronin, J Shen, K Blackburn, ED Booth, M Bouhifd, E Donley, ... Altex 33 (2), 149, 2016 | 191 | 2016 |
| Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities JP Bressler, L Olivi, JH Cheong, Y Kim, A Maerten, D Bannon Human & experimental toxicology 26 (3), 221-229, 2007 | 137 | 2007 |
| Analysis of Draize eye irritation testing and its prediction by mining publicly available 2008–2014 REACH data T Luechtefeld, A Maertens, DP Russo, C Rovida, H Zhu, T Hartung Altex 33 (2), 123, 2016 | 108 | 2016 |
| t4 workshop report: pathways of toxicity A Kleensang, A Maertens, M Rosenberg, S Fitzpatrick, J Lamb, ... Altex 31 (1), 53, 2014 | 108 | 2014 |
| Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function A Kleensang, MM Vantangoli, S Odwin-DaCosta, ME Andersen, ... Scientific reports 6 (1), 1-11, 2016 | 102 | 2016 |
| The human toxome project M Bouhifd, ME Andersen, C Baghdikian, K Boekelheide, KM Crofton, ... Altex 32 (2), 112, 2015 | 74 | 2015 |
| Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology C Rovida, T Barton-Maclaren, E Benfenati, F Caloni, PC Chandrasekera, ... Altex 37 (4), 579, 2020 | 71 | 2020 |
| Global analysis of publicly available safety data for 9,801 substances registered under REACH from 2008–2014 T Luechtefeld, A Maertens, DP Russo, C Rovida, H Zhu, T Hartung Altex 33 (2), 95, 2016 | 70 | 2016 |
| HistoneHits: a database for histone mutations and their phenotypes H Huang, AM Maertens, EM Hyland, J Dai, A Norris, JD Boeke, JS Bader Genome research 19 (4), 674-681, 2009 | 65 | 2009 |
| Analysis of publically available skin sensitization data from REACH registrations 2008–2014 T Luechtefeld, A Maertens, DP Russo, C Rovida, H Zhu, T Hartung Altex 33 (2), 135, 2016 | 64 | 2016 |
| Food for thought: green toxicology A Maertens, N Anastas, PJ Spencer, M Stephnes, A Goldberg, T Hartung | 63 | 2014 |
| Mapping the human toxome by systems toxicology M Bouhifd, HT Hogberg, A Kleensang, A Maertens, L Zhao, T Hartung Basic & clinical pharmacology & toxicology 115 (1), 24-31, 2014 | 60 | 2014 |
| Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells Y Kim, L Olivi, JH Cheong, A Maertens, JP Bressler Toxicology and applied pharmacology 220 (3), 349-356, 2007 | 58 | 2007 |
| The exposome: a new approach for risk assessment F Sillé, S Karakitsios, A Kleensang, K Koehler, A Maertens, GW Miller, ... | 56 | 2020 |
| Avoiding regrettable substitutions: Green toxicology for sustainable chemistry A Maertens, E Golden, T Hartung ACS sustainable chemistry & engineering 9 (23), 7749-7758, 2021 | 50 | 2021 |
| Analysis of public oral toxicity data from REACH registrations 2008–2014 T Luechtefeld, A Maertens, DP Russo, C Rovida, H Zhu, T Hartung Altex 33 (2), 111, 2016 | 49 | 2016 |
| t4 workshop report: Quality assurance of metabolomics M Bouhifd, R Beger, T Flynn, L Guo, G Harris, H Hogberg, ... Altex 32 (4), 319, 2015 | 44 | 2015 |
| Weighted gene correlation network analysis (WGCNA) reveals novel transcription factors associated with bisphenol A dose-response A Maertens, V Tran, A Kleensang, T Hartung Frontiers in genetics 9, 414481, 2018 | 43 | 2018 |
| Probabilistic risk assessment–the keystone for the future of toxicology A Maertens, E Golden, TH Luechtefeld, S Hoffmann, K Tsaioun, T Hartung Altex 39 (1), 3, 2022 | 42 | 2022 |
Thomas HartungChair for Evidence-based Toxicology, Johns Hopkins UniversityBestätigte E-Mail-Adresse bei jhsph.edu
